SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MorphoSys AG (MOR)
An SI Board Since January 2000
Posts SubjectMarks Bans
421 15 0
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
196MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's TGermanecki-3/28/2007
195MorphoSys Announces Change in Supervisory Board - Supervisory Board Nominates WaGermanecki-3/28/2007
194MorphoSys's AbD Serotec Expands Antibody License Agreement withMedical ReseaGermanecki-3/20/2007
193MorphoSys AG Reports Financial Results for Fiscal Year 2006 02/28/2007 at 07:30Germanecki-3/5/2007
192AbD Serotec and Thermo Fisher Scientific Sign Technology Agreement AbD Serotec Germanecki-2/14/2007
191MorphoSys Expands Japanese Alliance with GeneFrontier Thursday January 25, 1:59 nigel bates-1/25/2007
190MorphoSys Inaugurates New Facilities in Oxford, UK: UK Minister of Science MalcoGermanecki-1/22/2007
189MorphoSys Enlarges Therapeutic Antibody Collaboration With Pfizer - Expansion Donigel bates-12/20/2006
188GPC Biotech Presents Preliminary Clinical Data on Anticancer Monoclonal AntibodyGermanecki-12/16/2006
187Dutton Associates Announces Investment Opinion: MorphoSys AG Speculative Buy RatGermanecki-12/16/2006
186MorphoSys Presents New RapMAT(TM) Antibody Technology 12/11/2006 at 07:27 AM Germanecki-12/11/2006
185MorphoSys and the Burnham Institute Sign Broad Research Partnership 11/28/2006 Germanecki-11/28/2006
184MorphoSys and Boehringer Ingelheim Expand Collaboration With New Cancer-Related nigel bates-11/13/2006
183MorphoSys 3Q Figures Positive -Analyst Friday, October 27, 2006 5:04:35 AM ET Germanecki-10/27/2006
182MorphoSys Reports Nine Months 2006 Results Published: 07:30 27.10.2006 GMT+2 /HGermanecki-10/27/2006
181Invitation to Q3 2006 Conference Call of MorphoSys AG on October 27, 2006 MARTINGermanecki-10/22/2006
180On the run again! bigcharts.marketwatch.com A link to the presentation of a inGermanecki-10/6/2006
179MorphoSys and U.S. Army Enter into Biodefense Cooperation - MorphoSys's AbD Germanecki-9/25/2006
178Hi nigel bates, I am not used to the praxis of procurement of the US-army. Can Germanecki-9/14/2006
177US Army Medical Research Acquisition Activity For what is it for? SARS EBOLA AGermanecki-9/13/2006
176Partnerships Among Top 20 Pharmaceutical Companies Rank Company Initiated CurrenGermanecki-8/21/2006
175Dutton Associates Announces Investment Opinion: MorphoSys AG Strong Speculative Germanecki-8/21/2006
174MorphoSys Obtains PER.C6® Human Cell Line for Production of Antibody MateriGermanecki-8/21/2006
173AbD Serotec Opens New U.S. Office in Research Triangle Region August 4, 2006 &Germanecki-8/4/2006
172Morphosys 2Q Loss "No Cause For Worry" Monday, July 31, 2006 8:41:25Germanecki-7/31/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News